Quick Answer
IONIS PHARMACEUTICALS INC reported Stockholders Equity of $489.09 million for the year ending 2025.
- IONIS PHARMACEUTICALS INC showed a decrease of -16.9% in Stockholders Equity from 2024 to 2025.
- This data is from IONIS PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $262.23 million | Q3 2010: $253.71 million | Q3 2011: $186.83 million | Q1 2012: $150.87 million | Q2 2012: $154.31 million | Q3 2012: $170.28 million | Q1 2013: $201.09 million | Q2 2013: $401.08 million | Q3 2013: $401.45 million | Q1 2014: $374.10 million | Q2 2014: $366.86 million | Q3 2014: $344.77 million | Q1 2015: $275.85 million | Q2 2015: $300.32 million | Q3 2015: $245.41 million | Q1 2016: $158.16 million | Q2 2016: $111.21 million | Q3 2016: $139.64 million | Q1 2017: $201.81 million | Q2 2017: $215.57 million | Q3 2017: $307.97 million | Q1 2018: $301.39 million | Q2 2018: $696.26 million | Q3 2018: $710.55 million | Q1 2019: $1.21 billion | Q2 2019: $1.27 billion | Q3 2019: $1.34 billion | Q1 2020: $1.36 billion | Q2 2020: $1.38 billion | Q3 2020: $1.38 billion | Q1 2021: $680.56 million | Q2 2021: $582.67 million | Q3 2021: $530.54 million | Q1 2022: $709.57 million | Q2 2022: $624.73 million | Q3 2022: $594.36 million | Q1 2023: $486.57 million | Q2 2023: $428.30 million | Q3 2023: $315.46 million | Q1 2024: $296.52 million | Q2 2024: $263.70 million | Q3 2024: $662.47 million | Q1 2025: $475.73 million | Q2 2025: $631.72 million | Q3 2025: $617.97 million.
- Over the full 17 years of available data (2009 to 2025), IONIS PHARMACEUTICALS INC's Stockholders Equity has grown by 67.7%.
- Historical annual values: Fiscal year 2025: $489.09 million | Fiscal year 2024: $588.35 million | Fiscal year 2023: $386.69 million | Fiscal year 2022: $572.89 million | Fiscal year 2021: $771.74 million | Fiscal year 2020: $743.28 million | Fiscal year 2019: $1.47 billion | Fiscal year 2018: $1.05 billion | Fiscal year 2017: $281.01 million | Fiscal year 2016: $99.57 million | Fiscal year 2015: $200.79 million | Fiscal year 2014: $257.78 million | Fiscal year 2013: $378.39 million | Fiscal year 2012: $182.77 million | Fiscal year 2011: $171.43 million | Fiscal year 2010: $244.54 million | Fiscal year 2009: $291.72 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: